Trump’s FDA nominee faces Senate scrutiny as agency remains under acting leadership
Trump’s FDA nominee Heidi Overton still needs Senate confirmation while Kyle Diamantas remains acting commissioner and the FDA lists key vacancies and acting posts.
Trump’s FDA nominee Heidi Overton still needs Senate confirmation while Kyle Diamantas remains acting commissioner and the FDA lists key vacancies and acting posts.
On July 9, 2026, Trump removed the last confirmed Election Assistance Commission members, leaving the EAC commissioner-free as states prepare for 2026.